Human lung organoid modelling of tissue-resident antiviral T cell responses
->Nature | More on "Lung tissue-resident memory T cells" at BigEarthData.ai | #Coronavirus #Antiviral
NanoViricides (NYSE: NNVC) will present at the NIBA 153rd Investment Conference Oct. 7, 2026. Their lead drug NV-387 is in Phase 2 trials for Ebola and Mpox, with FDA designations for measles treatment. A pipeline worth watching. #Biotech #Antiviral
